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The FAM3 superfamily is predicted to contain clas-
sical four-helix bundle cytokines, featuring a typical
up-up-down-down fold. Two members of FAM3
have been extensively studied. FAM3B PANDER
has been shown to regulate glucose homeostasis
and b cell function, whereas the homologous
FAM3C ILEI has been shown to be involved in epithe-
lial-mesenchymal transition and cancer. Here, we
present a three-dimensional structure of a FAM3
protein, murine PANDER. Contrary to previous
suggestions, PANDER exhibits a globular b-b-a
fold. The structure is composed of two antiparallel
b sheets lined by three short helices packing to
form a highly conserved water-filled cavity. The fold
shares no relation to the predicted four-helix
cytokines but is conserved throughout the FAM3
superfamily. The available biological data and the
unexpected new fold indicate that FAM3 PANDER
and ILEI could represent a new structural class
of signaling molecules, with a different mode of
action compared to the traditional four-helix bundle
cytokines.
INTRODUCTION
The family with sequence similarity 3, FAM3, was identified in
2002 based on a search using the ostensible recognition of folds
(ORF) method that screened genomic databases in an effort
to identify new cytokines. Many cytokines, like interleukins (IL)-
2, -3, -4, -5, -6, -7, -9, -10, and -13; granulocyte-macrophage
colony-stimulating factor, andgrowth hormone, share a common
four-helix bundle structure despite very low sequence similarity.
FAM3was hypothesized to contain a similar cytokine fold with an
up-up-down-down topology stabilized by two disulfide bonds
(Zhu et al., 2002). The superfamily is composed of four identified
members, FAM3A, -B, -C, and -D. Little is known about FAM3A
and FAM3D, whereas more data have been accumulated for306 Structure 21, 306–313, February 5, 2013 ª2013 Elsevier Ltd All rFAM3B and FAM3C. The FAM3B was later named pancreatic-
derived factor (PANDER) in 2003 due to robust expression in
the endocrine pancreas (Cao et al., 2003). Since then, the factor
has been shown to be involved in the regulation of glucose
homeostasis and b cell function (Wang et al., 2012; Wilson
et al., 2011; Yang et al., 2005a), whereas the FAM3C inter-
leukin-like epithelial-mesenchymal transition (EMT) inducer
(ILEI) has been shown to be involved in EMT and cancer
(Waerner et al., 2006).
Proteins of the FAM3A–FAM3D families are all around 230
amino acids in length and share about 20%–40% sequence
identity, with no significant similarity to any known cytokines.
All four members are suggested to be secreted proteins,
although cytoplasmic populations of FAM3B and FAM3C have
been reported (Lahsnig et al., 2009; Waerner et al., 2006; Yang
et al., 2005b). So far, no receptors have been identified for any
of the different FAM3 families.
FAM3B PANDER was initially described to be predominantly
expressed in the pancreas (Zhu et al., 2002), colocalizing with
insulin in the secretory granules of b cells and in the glucagon-
negative granular cytosolic compartment of a cells (Carnegie
et al., 2010), and to be cosecreted with insulin in response to
glucose. Based on the prediction that FAM3B would feature
a typical four-helix bundle fold, several groups have worked at
elucidating its function as a secreted cytokine using biochem-
ical, in vivo, and cell biology methods (Wang et al., 2012; Yang
et al., 2005a; for a review, see Wilson et al., 2011). Initial func-
tional characterization showed that exogenous treatment with
recombinant PANDER, or its intracellular overexpression via
adenoviral delivery, induced apoptosis in a and b cell lines as
well as in mouse, rat, and human islets (Burkhardt et al., 2006;
Cao et al., 2003, 2005) via a caspase-3-dependent mechanism
(Burkhardt et al., 2006). In all studies, recombinant PANDER
mixtures of different species have been used, and the active
variant has, to date, not been identified (Zhu et al., 2002).
Although PANDER treatment of isolated murine islets did not
affect glucose-stimulated insulin secretion (GSIS), it did impair
insulin secretion in response to various insulin secretagogues
(Cao et al., 2005), suggesting an effect on the amplifying signals
of insulin secretion. In 2009, Yang et al. showed that PANDER
interacted with an unidentified receptor on liver cells and inter-
fered with insulin signaling and uptake of glucose (Yang et al.,ights reserved
Figure 1. Quality Control of Recombinant PANDER and Functional
Apoptosis Data
(A) Construct design for mP (S)E30 and mP S46 with protein used in crystal-
lization indicated by arrows. CD33 leader sequence, His6 tag, TEV recognition
site, and FLAG tag are shown.
(B) SDS-PAGE with different PANDER batches: mP (S)E30 load (L) before ion
exchange chromatography (IEX) and at Peak 1 (1), Peak 2 (2), and Peak 3 (3)
after IEX; and mP S46 before (T-) and after (T+) TEV cleavage.
(C) Separation of mP (S)E30 by IEX; (1) mP (S)E30-K243 without glycosylation,
(2) mP (S)E30-D242 without glycosylation, and (3) O-glycosylated PANDER
with variable amino acid length.
(D) Apoptotic activity of mP (S)E30 after 48 hr incubation with INS1 cells.
Values represent the percentage of Yo-Pro positive apoptotic cells relative to
total cell population at each concentration. Positive control for inducing
apoptosis is a mix of the cytokines IL1b, TNFa, and IFNg at concentrations of
20, 40, and 40 ng/ml respectively. Error bars indicate means ± SEM of three
independent experiments.
(E) Melting temperatures of the different PANDER proteins as measured by
thermal melting analysis.
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Structure 21, 302009). PANDER has also been shown to be expressed in the liver
and to be upregulated in diabetic insulin-resistant mice (Li et al.,
2011). To date, several different functions of FAM3B PANDER
have been suggested based on the apoptotic effect on a and
b cells (Burkhardt et al., 2006; Cao et al., 2003, 2005), including
the amplification of insulin secretion signals in b cells (Yang et al.,
2005b) and regulation of hepatic glucose production (Robert-
Cooperman et al., 2010, 2011; Wilson et al., 2010).
FAM3C ILEI was initially identified as a candidate gene
involved in nonsyndromic hearing loss (Greinwald et al., 1998)
with high levels of expression in inner ear and laminar retina
(Katahira et al., 2010; Pilipenko et al., 2004). However, in 2006,
Waerner and coworkers showed that ILEI is involved in EMT
(Waerner et al., 2006), a central process in the progression
of cancer (Thiery et al., 2009). The authors showed that stable
overexpression or addition of recombinant ILEI to mammary
epithelial cells induced EMT, leading to cancer and metastasis
formation. Cytoplasmic expression of ILEI was found to correlate
with a significant decrease inmetastasis-free and overall survival
in breast cancer patients, whereas downregulation of ILEI was
found to attenuate the induction of EMT (Chaudhury et al.,
2010; Hussey et al., 2011). It is interesting that cytoplasmic
ILEI levels did not correlate with other clinical biomarkers,
suggesting that ILEI could potentially serve as an independent
prognostic marker in breast cancer (Waerner et al., 2006).
A number of studies have been directed toward the functional
effects and regulation of both FAM3B PANDER and FAM3C ILEI.
However, less is known about the mode of action of the indi-
vidual proteins. In the experiments performed by Yang et al.,
recombinant PANDER variants were transiently expressed in
the mouse insulinoma cell line bTC3, and the percentage of
apoptosis wasmeasured (Yang et al., 2005a) as well as the effect
on secretion of PANDER (Yang et al., 2005b). At the time, these
results appeared to strengthen the hypothesis that FAM3B
PANDER was an islet-specific cytokine with the canonical four-
helix bundle fold and two disulfide bonds between C63-C69
and C91-C229 (Yang et al., 2005a). The authors further sug-
gested that the central region of PANDER between amino acids
91 and 152 and the disulfide bond C91-C229 was important for
the secretion and apoptotic activity of PANDER.
In this study, we present a three-dimensional structure of
mouse FAM3B PANDER, expressed at high levels, purified
from HEK-EBNA cells, and solved by sulfur single anomalous
dispersion (S-SAD). The structure exhibits a protein fold with
no relation to the predicted four-helix bundles, indicating that
the FAM3 superfamily might represent a new class of signaling
molecules, possibly with different functions than that of the
predicted cytokines. The presented structure will be instru-
mental for the design of experiments to further elucidate struc-
ture-function relationships not only for PANDER but also for
ILEI and the other FAM3 family members.
RESULTS AND DISCUSSION
Two constructs of recombinant mouse PANDER corresponding
to (S)E30-R235 PANDER and a truncated version starting at
amino acid S46, S46-R235 PANDER, were used in this study
(Figure 1A). In both cases, the native signal peptide was replaced
with a CD33 signal peptide (MPLLLLLPLLWAGALA). Both6–313, February 5, 2013 ª2013 Elsevier Ltd All rights reserved 307
Table 1. Data Collection and Refinement Statistics
PANDER S46 S-SAD PANDER (S)E30
Data Collection
Images/oscillation () 7,200/0.1 100/2
Space group P212121 P31
Cell dimensions (A˚) 42.9, 90.4, 185.1 86.5, 86.5, 96.3
Resolution (A˚) 2.30–30.0 (2.30–2.42) 2.35–34.5 (2.35–2.43)
Rmerge 0.091 (0.66) 0.134 (0.79)
I/sI 26.9 (2.2) 11.2 (2.6)
Completeness (%) 97.4 (83.2) 99.9 (99.7)
Redundancy 20.9 (7.2) 4.3 (4.1)
Resolution (A˚) 2.30–30.0 2.35–21.7
Measured reflections 672,720 144,685
Unique reflections 32,116 33,513
Refinement
Rwork/Rfree 0.187/0.229 0.158/0.190
No. atoms
Protein 4,239 4,276
Water 320 412
Average B Factors
Protein (A˚2) 46.3 34.0
Water (A˚2) 47.1 40.6
Ramachandran
outliers (%)
1.3 1.1
RMSD
Bond lengths (A˚) 0.010 0.010
Bond angles () 1.19 1.16
Values in parentheses refer to highest resolution shell.
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recognition sequence, and a C-terminal FLAG tag (Figure 1A).
An extra Serine was added to the N terminus of (S)E30 PANDER
to enable efficient cleavage of the His tag by TEV protease
(Kapust et al., 2002). Both (S)E30 and S46 PANDER were
successfully expressed, processed, secreted, and purified using
a HEK-EBNA system as described in the Experimental Pro-
cedures and Supplemental Experimental Procedures (available
online). His tags were removed as a final purification step fol-
lowed by size exclusion chromatography. Both proteins were
quality checked by SDS-PAGE, N-terminal sequencing, and
mass spectrometry (spec) analysis. The N-terminal sequencing
showed that both proteins were uniformly processed at the
N terminus, whereas the mass spec analysis revealed that
the C-terminal Lysine had been removed from the FLAG tag
during protein production (Harris, 1995). Mass spec analysis
together with SDS-PAGE suggested that (S)E30 PANDER
contained O-linked glycosylations based on the characteristic
mass increase of up to 3 3 947 Da that matches a typical
O-linked GalNacGal(NeuAc)2 structure (Thim et al., 2010),
whereas S46 PANDER appeared to be unglycosylated (data
not shown). The different variants of (S)E30 PANDER, shown
in Figure 1B, lane L, were separated by anion exchange chro-
matography; thus, pure unglycosylated (S)E30-D242 PANDER
was secured for downstream applications (Figure 1C, peak 2).
The HEK-EBNA system described here enables production of
N-terminal intact PANDER protein in comparison to a previously
reported Pichia pastoris system that suffered from proteolytic
degradation (Zhu et al., 2002). In the presented study, uniformly
N-terminal processed PANDER corresponding to full-length
protein with signal peptide removed was available for in vitro
assays. Yields of purified secreted protein were increased
several fold by switching the native signal peptide to a CD33
peptide (data not shown) with final yields of 50 and 100 mg/l
culture for the (S)E30 and S46 constructs, respectively. Similarly,
mutations in the signal peptide led to increased detection of
secreted PANDER in an earlier study (Yang et al., 2005b), sug-
gesting that the native PANDER signal sequence is not optimal
for expression and/or secretion.
The (S)E30 PANDER protein showed clear dose-dependent
apoptotic activity against rat INS1 insulinoma cells (Figure 1D).
However, the observed activity was significantly lower than
that in earlier reports of murine PANDER, produced in Pichia
pastoris, using the mouse insulinoma cell line bTC3 (Cao et al.,
2003). This disparity could be due to the different expression
systems, the rat/mouse species differences, and/or differing
expression levels of a putative PANDER receptor. In addition,
all previous studies have usedmixtures of recombinant PANDER
protein starting at S46 and A55 (Zhu et al., 2002). Curiously,
according to literature, production of recombinant ILEI also
results in protein products with different N-terminal starts and
varying activity (Waerner et al., 2006).
PANDER Structure
Murine S46 and unglycosylated (S)E30 PANDER, separated
from glycosylated variants through anion exchange, were con-
centrated and crystallized using vapor diffusion. The PANDER
S46 structure was solved by S-SAD in space group P212121
using highly redundant X-ray data collected at 6 keV to a resolu-308 Structure 21, 306–313, February 5, 2013 ª2013 Elsevier Ltd All rtion of 2.3 A˚. Due to the limited resolution, the anomalous sulfur
signal did not extend beyond 4.5 A˚. However, by careful location
and splitting of the disulfide bridges, initial S-SAD phases could
be obtained to 3.7 A˚ and phase-extended to 2.3 A˚ resolution. The
PANDER (S)E30 crystals were found to belong to space
group P31, and data were collected to 2.35 A˚ resolution. Both
the orthorhombic S46 and the trigonal (S)E30 crystal forms
contain three molecules per asymmetric unit and show only
minor differences, with a root-mean-square deviation (RMSD)
of 0.1–0.5 A˚ across all sixmolecules. Full phasing and refinement
statistics can be found in Table 1.
Already from initial low resolution maps, it was clear that
PANDER is not an all a-helical protein. The PANDER structure
exhibits a b-b-a three-layer architecture with two antiparallel
b sheets and one layer of three short helices (Figure 2). The first
b sheet is composed of four strands ordered 9-1-2-3, while
the second holds five with a topology of 8-7-6-4-5. The core of
the PANDER fold is mainly hydrophobic. However, a closed
110 A˚3 water-filled cavity is formed by loops between the two
b layers. The N terminus (Arg60-Asp72) forms a small structured
domain, stabilized by two disulfide bridges, Cys63-Cys91 and
Cys69-Cys229. This is strikingly different from the proposed
Cys63-Cys69/Cys91-Cys229 disulfide topology suggested by
mutational studies (Yang et al., 2005a).
The first 29 amino acids after the PANDER signal peptide
could not be seen in any of the two structures, althoughights reserved
Figure 2. The FAM3 b-b-a Fold
(A) The predicted four-helical fold and cysteine
bridge topology (Yang et al., 2005a).
(B) Murine PANDER solved to 2.3 A˚ resolution,
colored from blue to red from N terminus to
C terminus. Disulphide topology is indicated by
dashed lines.
(C) The ab initio-designed TOP7 b-a-fold (Kuhlman
et al., 2003).
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protein was present in crystals. The PANDER Glu30-Lys59 N
terminus is thus likely to be unstructured. Truncation studies
based on a predicted four-helix bundle cytokine-like fold
indicated that the removal of amino acids 31–90 resulted in
essentially no changed effect on cytotoxic activity (Yang et al.,
2005a). This is surprising given that such an N-terminal trunca-
tion would also cut b1 and b2 as well as both disulfide bridges
(Figure 2B). However, in a follow-up study, the same authors
reported that none of the truncated PANDER constructs could
be found in the concentrated medium of overexpressing cells
(Yang et al., 2005b), suggesting that the full integrity of the
b-b-a fold described here is critical for PANDER stability and/
or secretion.
A search of the PANDER structure in the DALI fold database
resulted in a number of hits with remotely related secondary
structure. The most similar structure, with a Z score of 3.3,
was the artificially designed TOP7 protein (Protein Data Bank
[PDB] code 1QYS), sharing a related C-terminal b-a architecture
(Figure 2C). Many structures, like PDB IDs 3MX7 and 2LC1
with a b-b and 2AB1 with an a-b-a fold exhibit some similarity
with the PANDER structure but with different b sheet
topology. The lack of naturally occurring structures with the
same topology and the partial similarity to TOP7, designed to
explore new regions of the protein universe (Kuhlman et al.,
2003) strengthens the view that PANDER represents a new
protein fold.
To explore the relationship between PANDER, ILEI, and the
different FAM3 families, sequences were gathered by an itera-
tive approach and aligned (Figure 3A). A homology model of
ILEI was constructed based on the 36% identity and 59%
amino acid similarity to PANDER. The FAM3A, -B, -C, and -D
families share several highly conserved regions, indicating that
they all are likely to adopt a similar b-b-a fold. The highest
conservation across FAM3 is found in b1, b2, b4, and in the
link between a2 and a3, as well as in b10 and in the beginning
of b12, whereas the highest variation is found in between the
secondary structure elements as well as in the N terminus, in
b3, b5, a1, and a3.
The PANDER structure is connected by a large number of
electrostatic interactions. Many of these are also conserved
in ILEI, like Lys62-Glu93, Arg60-Asp94, and Arg77-Glu227,
whereas a few like Glu203-Lys206 are only conserved in the
FAM3B family. Some of the salt bridges have been shifted in
ILEI, like the bidentate Lys86-Glu223-Arg216 that is replacedStructure 21, 306–313, February 5, 2013by Lys208-Glu214 in ILEI; or some have
switched polarity, like Asp169-Lys180-
Glu172. FAM3C also seems to have anumber of salt bridges unique to ILEI and a few neighboring
proteins, like Glu66-Lys67, Lys72-Glu217, and Glu134-
Lys137. However, many of the electrostatic interactions in
PANDER, like Asp133-Lys162 and Arg107-Asp128, are likely to
exist in all FAM3 families (Figure S1).
To explore the potential functionally important areas, the
PANDER structure was subjected to a computational prediction
of active-site residues using a maximum likelihood algorithm
(Tong et al., 2009). It is interesting that the predicted residues
coincide with two conserved clusters at both ends of the mole-
cule. The first cluster is centered around the small N-terminal
domain that connects to b2 and b9 via the two conserved
cysteine bridges. The N-terminal domain and the curved b sheet
create a shallow, 10 to 15 A˚-wide groove. This groove is partially
filled by the C terminus of a neighboring molecule in two out of
three molecules of the S46 crystal form and in all molecules of
the (S)E30 crystal form, stacking perpendicularly on to the
b sheet (Figure S2). However, only a small number of the
observed peptide-protein interactions seem to be conserved in
FAM3B or any of the other FAM3 families.
The second cluster is located around the small closed cavity
on the lower side of the structure. Several of the residues lining
the pocket, like Gly81, Asp157, Tyr217, Trp220, and Pro221,
are conserved not only in ILEI but throughout the FAM3 super-
family; and the remaining residues, Gly82, Gly83, Thr155, and
Ser187, are partially conserved (Figures 3A and 3C). The pocket
contains four well-coordinated water molecules interacting with
main chain hydroxyl and amide nitrogens of neighboring resi-
dues. The access between the pocket and the bulk solvent is
in PANDER primarily blocked by Trp220, wedged between the
side chains of Arg84 and Arg185 (Figure S3).
Enclosed cavities are generally rare in proteins due to
their impact on conformational stability (Eriksson et al., 1992;
Sandberg and Terwilliger, 1989). However, the high conserva-
tion of the area around the pocket throughout FAM3 indicates
that it might be important. This is also supported by an
Arg187 mutation in the FAM3-domain containing KIAA1199
protein causing nonsyndromic hearing loss (Abe et al., 2003).
Arg187 is highly conserved over evolutionarily distant species
across the entire FAM3, suggesting that substitutions could
affect the function of KIAA1199. The disease-causing mutation
is likely to break a conserved salt bridge one layer away from
the pocket, corresponding to Arg107-Asp128 in PANDER and
Arg102-Asp123 in ILEI (Figures 3A and 3B; Figure S3). Although
buried cavities have been indicated to introduce nativeª2013 Elsevier Ltd All rights reserved 309
Figure 3. FAM3 Sequence Conservation
(A) Structure-based sequence alignment of the FAM3A, -B, -C, and -D families. The Arg107-Asp128 salt bridge is indicated by an asterisk, and the W220
gatekeeper residue is indicated by a currency sign.
(B) PANDER surface colored according to FAM3 sequence conservation from dark blue (high) to white (low). Arg107, corresponding to the KIAA1199 disease-
causing Arg187 mutation highlighted in red.
(C) FAM3 conservation in the vicinity of the water-filled cavity with absolutely conserved side chains shown as sticks. For details of the water pocket, see
Figure S3.
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2000), this seems unlikely. Both the Trp220 gatekeeper residue
and the region around the cavity have significantly lower B
factors compared to the rest of the protein in all six inde-
pendent molecules of the two crystal systems (Figure S4),
indicating a low local flexibility. The 59C melting temperature,
determined by thermal melting experiments, also indicates310 Structure 21, 306–313, February 5, 2013 ª2013 Elsevier Ltd All rPANDER to be a relatively stable protein (Figure 1E), compared
to an overall average around 50C in a study of 657 proteins
from 45 different species (Dupeux et al., 2011). Since the
water-filled cavity is not accessible from the bulk solvent and
is part of a thermally stable region of the structure, the features
around the pocket may be an evolutionary remnant from an
ancient FAM3-like protein that has adopted a new function,ights reserved
Figure 4. PANDER/ILEI Conservation
(A and B) PANDER surface colored according to
ILEI conservation from dark green (high) to white
(low).
(C) Electrostatic potential of PANDER from +2
to 2 mV.
(D and E) ILEI model colored according to
PANDER conservation from dark green (high) to
white (low).
(F) Electrostatic potential of ILEI model from +2
to 2 mV.
See also Figure S1.
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interactions.
In contrast to the limited surface conservation across the
entire FAM3A-D (Figure 3B), PANDER and ILEI share a large
conserved surface area. Interestingly, the majority of the
conserved residues cluster on one side of the molecule (Figures
4B and 4E). FAM3B also have some additional conserved
patches around Glu223 and Ile207, whereas FAM3C and ILEI
have a unique conserved surface around Val81 and Lys97,
including the inverted polarity of a few charged residues and
salt bridges like Lys86-Glue223-Arg216 and Asp169-Lys-180
(PANDER numbering). Despite the overall homology, PANDER
and ILEI are likely to exhibit different electrostatic properties,
indicating that they might interact with a similar class but
different subtype of binding partners (Figures 4C and 4F).
Reexamination of the earlier truncation studies (Yang et al.,
2005a, 2005b) using the PANDER structure show that many of
the truncations were made to the core of the protein, cutting
out strands b7, b8, and b9, which harbor a significant proportion
of the FAM3-conserved residues (Figure 3A). Thus, it is not
surprising that a majority of the deletions and truncations turned
out to be critical for processing and secretion as well as
apoptotic activity.
Since the discovery of the FAM3 family, the view of its function
has broadened and become more complex. FAM3B PANDER
was originally described to be an islet-specific cytokine with
apoptotic activity (Burkhardt et al., 2006; Cao et al., 2003) (Fig-
ure 1D). Based on the new structure and existing literature, we
speculate that PANDER effects b cells in a different way
compared to traditional apoptotic cytokines that act through
interaction with cell-death receptors and activation of Caspase
3 (Cnop et al., 2005). Since Caspase 3 acts in the execution
phase of apoptosis, its activation by PANDER could also be
mediated by intracellular stress mechanisms, independent of
cell-death receptor activation (Chipuk et al., 2010; Riedl and
Salvesen, 2007). The novel structure and dissemblance to
traditional cytokines give support to later findings where
PANDER is described to be a hormone involved in negativeStructure 21, 306–313, February 5, 2013regulation of b cell function and liver
glucose homeostasis (Wilson et al.,
2011) interfering with insulin-stimulated
activation of the insulin receptor and
downstream elements such as IRS1,
PI3K, and pAKT (Yang et al., 2009). This
is also supported by crosslinking ofPANDER to HepG2 cells (Yang et al., 2009). FAM3C ILEI was
originally described to be involved in nonsyndromic hearing
loss (Greinwald et al., 1998) and, more recently, to be a key
protein in EMT and metastasis formation (Chaudhury et al.,
2010; Hussey et al., 2011;Waerner et al., 2006). However, similar
to PANDER, no ILEI receptor or definitive signaling pathway
has been identified, making it hard to classify its mode of action
during EMT. Thus, for both PANDER and ILEI, it is critical to
identify the receptors on b cells, liver cells, and epithelial cells
to elucidate the biology and to gain a unified view of the protein
function. Deconvolution of potential PANDER partners could,
for example, be possible using the robust protein production
system described here and targeted cells combined with novel
and more sensitive techniques for receptor identification
(Frei et al., 2012).
The PANDER structure will be a valuable tool for further
investigation of the elusive function of the FAM3 proteins.
Both PANDER and ILEI share a similar b-b-a fold, strikingly
different from the classical cytokines like the four-helix bundle
family (Bazan, 1992), the TNF family (Jones et al., 1989), the
b-trefoil family (Priestle et al., 1989), or the cysteine-knot
growth factor family (McDonald et al., 1991). The unexpected
fold together with the pleiotropic effects of FAM3B and FAM3C
open up the possibility that they might represent a new distinct
signaling system conserved throughout vertebrate evolution.EXPERIMENTAL PROCEDURES
Transient Expression, Purification, Quality Check, and Activity
Testing of PANDER
Murine PANDER protein from two constructs, mP (S)E30 and mP S46, were
transiently expressed in suspension-adapted HEK293 cells (National
Research Council, Ottawa, Ontario, Canada). Proteins were batch purified
with NiNTA Superflow (QIAGEN) followed by size exclusion chromatography.
For the crystallization studies, mP (S)E30 was further purified by anion
exchange chromatography (PolyWAX LP, 4.6 3 150 mm, 5 mm, 1,000 A˚,
Poly LC) to remove glycosylated variants of the protein. Full details of protein
expression, purification, protein quality check and activity can be found in
Supplemental Experimental Procedures.ª2013 Elsevier Ltd All rights reserved 311
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PANDER Structure Reveals New Noncytokine FoldCrystallization, S-SAD Phasing, and Refinement
The two PANDER constructs were crystallized by vapor diffusion techniques
using 2-methyl-2,4-pentanediol and polyethylene glycol. Crystals of murine
PANDER S46 were found to belong to space group P212121, whereas crystals
of mP (S)E30 belonged to space group P31. To increase the anomalous
sulfur signal, data on a single S46 crystal were collected at the European
Synchrotron Radiation Facility, beamline ID29, using an X-ray wavelength of
2.1 A˚/6kV in line with previous studies (Mueller-Dieckmann et al., 2005). The
sulfur substructure was solved using ShelxD (Sheldrick, 2008) and split into
separate atoms. To improve phasing power, the S-SAD parameters were
iteratively rerefined using density modification Hendrickson Lattman coeffi-
cients as phase restraints. The phase estimates were finally subjected to
statistical density modification and phase-extended to 2.3 A˚. Full details of
data collection and structure solution can be found in the Supplemental
Experimental Procedures and Table 1.
ACCESSION NUMBERS
S46 coordinates and structure factors have been deposited in the PDB with
ID 2YOP and (S)E30 coordinates and structure factors with 2YOQ.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.str.2012.12.009.
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